The distinct expression of FGF5 in recurrent NPC samples along with its regulatory relationship with DNA methylation identify FGF5 as a key player in the pathogenesis of NPC and a promising target for therapeutic intervention. Here, FGF5 is linked to nasopharyngeal carcinoma.